Breaking News
More () »

VERIFY: What is the true cost of new ALS drug?

Jane McCarthy

Play Video

Close Video

ALS patients and families across the country are applauding the FDA for fast-tracking a drug that could slow the decline of physical function by 33 percent.

The drug is called Radicava and it is the first new treatment approved specifically for ALS in 22 years.

The drug’s list price is $1,000 per infusion, which amounts to $146,000 a year.

KREM 2 set out to verify the following:

At that cost, will most patients be able to access the new drug?

What does Radicava do?

Is this a breakthrough?